Literature DB >> 18456744

Locally recurrent or metastatic breast cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

V Kataja1, M Castiglione.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18456744     DOI： 10.1093/annonc/mdn072

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  13 in total

1.  Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner.

Authors:  Lisa Volk-Draper; Kelly Hall; Caitlin Griggs; Sandeep Rajput; Pascaline Kohio; David DeNardo; Sophia Ran
Journal:  Cancer Res       Date:  2014-10-01       Impact factor: 12.701

2.  Surgical Procedures and Methodology for a Preclinical Murine Model of De Novo Mammary Cancer Metastasis.

Authors:  Charles E Gast; Aubie K Shaw; Melissa H Wong; Lisa M Coussens
Journal:  J Vis Exp       Date:  2017-07-29       Impact factor: 1.355

3.  Combined-modality radioimmunotherapy: synergistic effect of paclitaxel and additive effect of bevacizumab.

Authors:  Beom-Su Jang; Sang-Myung Lee; Hyung Sub Kim; In Soo Shin; Faezeh Razjouyan; Shutao Wang; Zhengsheng Yao; Ira Pastan; Matthew R Dreher; Chang H Paik
Journal:  Nucl Med Biol       Date:  2011-12-14       Impact factor: 2.408

Review 4.  Exemestane: a review of its use in postmenopausal women with breast cancer.

Authors:  Emma D Deeks; Lesley J Scott
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 5.  Treatment options for breast cancer resistant to anthracycline and taxane.

Authors:  Alvaro Moreno-Aspitia; Edith A Perez
Journal:  Mayo Clin Proc       Date:  2009-06       Impact factor: 7.616

6.  Safety and Efficacy of nab-Paclitaxel in the Treatment of Patients with Breast Cancer.

Authors:  Prakash Vishnu; Vivek Roy
Journal:  Breast Cancer (Auckl)       Date:  2011-04-13

Review 7.  International guidelines for management of metastatic breast cancer: can metastatic breast cancer be cured?

Authors:  Olivia Pagani; Elzbieta Senkus; William Wood; Marco Colleoni; Tanja Cufer; Stella Kyriakides; Alberto Costa; Eric P Winer; Fatima Cardoso
Journal:  J Natl Cancer Inst       Date:  2010-03-10       Impact factor: 13.506

8.  A multicentric observational trial of pegylated liposomal doxorubicin for metastatic breast cancer.

Authors:  Jens Huober; Werner Fett; Arnd Nusch; Michael Neise; Marcus Schmidt; Arthur Wischnik; Steffen Gerhardt; Thomas Goehler; Hans-Joachim Lück; Andreas Rost
Journal:  BMC Cancer       Date:  2010-01-05       Impact factor: 4.430

9.  Phase I and II Study of Gemcitabine and Vinorelbine in Heavily Pretreated Patients with Metastatic Breast Cancer and Review of the Literature.

Authors:  Pamela Abdayem; Marwan Ghosn; Vicente Valero; Ronald Walters; Banu Arun; James L Murray; Richard Theriault; Debbie Frye; Nuhad K Ibrahim
Journal:  J Cancer       Date:  2014-03-29       Impact factor: 4.207

10.  All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II Trial.

Authors:  N Tubiana-Mathieu; P Bougnoux; D Becquart; A Chan; P-F Conte; F Majois; M Espie; M Morand; N Vaissiere; G Villanova
Journal:  Br J Cancer       Date:  2009-07-07       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.